Breast Cancer
This new series of case-based microlearning courses are designed to help pathologists and laboratory professionals increase their knowledge, skills, and competence in applying practice-changing updates regarding HER2-low and HER2-ultralow advanced breast cancer.
This is the first of three activities and focuses on HER2 classification, tracking, and reporting considerations for HER2 IHC testing and interpretations in HER2-low breast cancers.
In the second portion of this three-part activity we focus on the emerging science of HER2-low and HER2-ultralow then go into current treatment for HER2-low and HER2-ultralow patients.
In this final part of the three activities, the focus is on reproducibility of testing and clinical significance of HER2-low and HER2-ultralow.
This microlearning series is supported by independent educational grants from AstraZeneca Pharmaceuticals and Daiichi Sankyo, Inc.
This CME/CMLE-accredited, case-based microlearning activity is designed to help pathologists and laboratory professionals increase their knowledge, skills, and competence in testing and diagnosing breast cancer across the HER2 spectrum.
Every few days, participants will be emailed or sent several questions through the Qstream app. Each question consists of an authentic patient case/scenario and an assessment question with 3-5 multiple-choice answers designed to help you make an appropriate diagnosis/recommendation.
This case-based microlearning activity includes the following topics:
Upon completion of this activity, you should be able to:
Swikrity U. Baskota, MD, Assistant Professor of Pathology and Cell Biology, Columbia University Medical Center
Poonam Vohra, MD, FASCP, Associate Professor, Anatomic Pathology, University of California, San Francisco
Faculty Disclosures: Swikrity U. Baskota, MD, and Poonam Vohra, MD, FASCP, have no relevant financial relationships to disclose.
The activity offers 1.0 CME/CMLE credit.
This course allows you to claim credit once you have completed the microlearning education in QStream and received your completion notice via email. Do not attempt to claim credit until you have completed the microlearning education in QStream. To register, take the following steps.
The American Society for Clinical Pathology (ASCP) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians.
The ASCP designates this online microlearning activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.